Association between SGLT-2 inhibitors and suicide risk in type 2 diabetes and bipolar: a real-world cohort study

BackgroundIndividuals with bipolar disorder face a significantly elevated suicide risk, and comorbid type 2 diabetes mellitus (T2DM) further complicates their psychiatric and medical outcomes. Sodium–glucose co-transporter-2 inhibitors (SGLT-2i) have demonstrated cardiometabolic benefits in T2DM, bu...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: En-Wei Chang, Jing-Yang Huang, Shih-Chang Lo, Chien-Ning Huang, Yi-Sun Yang, Edy Kornelius
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Subjects:
bipolar
diabetes
SGLT2
DPP4
cohort study
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1601118/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1601118/full

Similar Items